3pds
From Proteopedia
(Difference between revisions)
(4 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
+ | |||
==Irreversible Agonist-Beta2 Adrenoceptor Complex== | ==Irreversible Agonist-Beta2 Adrenoceptor Complex== | ||
- | <StructureSection load='3pds' size='340' side='right' caption='[[3pds]], [[Resolution|resolution]] 3.50Å' scene=''> | + | <StructureSection load='3pds' size='340' side='right'caption='[[3pds]], [[Resolution|resolution]] 3.50Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[3pds]] is a 1 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[3pds]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Escherichia_virus_T4 Escherichia virus T4] and [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3PDS OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3PDS FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CLR:CHOLESTEROL'>CLR</scene>, <scene name='pdbligand=ERC:8-HYDROXY-5-[(1R)-1-HYDROXY-2-({2-[3-METHOXY-4-(3-SULFANYLPROPOXY)PHENYL]ETHYL}AMINO)ETHYL]QUINOLIN-2(1H)-ONE'>ERC</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3.5Å</td></tr> |
- | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CLR:CHOLESTEROL'>CLR</scene>, <scene name='pdbligand=ERC:8-HYDROXY-5-[(1R)-1-HYDROXY-2-({2-[3-METHOXY-4-(3-SULFANYLPROPOXY)PHENYL]ETHYL}AMINO)ETHYL]QUINOLIN-2(1H)-ONE'>ERC</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | |
- | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3pds FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3pds OCA], [https://pdbe.org/3pds PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3pds RCSB], [https://www.ebi.ac.uk/pdbsum/3pds PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3pds ProSAT]</span></td></tr> | |
- | + | ||
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
== Function == | == Function == | ||
- | [ | + | [https://www.uniprot.org/uniprot/ADRB2_HUMAN ADRB2_HUMAN] Beta-adrenergic receptors mediate the catecholamine-induced activation of adenylate cyclase through the action of G proteins. The beta-2-adrenergic receptor binds epinephrine with an approximately 30-fold greater affinity than it does norepinephrine.[https://www.uniprot.org/uniprot/ENLYS_BPT4 ENLYS_BPT4] Endolysin with lysozyme activity that degrades host peptidoglycans and participates with the holin and spanin proteins in the sequential events which lead to the programmed host cell lysis releasing the mature viral particles. Once the holin has permeabilized the host cell membrane, the endolysin can reach the periplasm and break down the peptidoglycan layer.<ref>PMID:22389108</ref> |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 19: | Line 18: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
+ | <div class="pdbe-citations 3pds" style="background-color:#fffaf0;"></div> | ||
==See Also== | ==See Also== | ||
- | *[[Adrenergic receptor|Adrenergic receptor]] | + | *[[Adrenergic receptor 3D structures|Adrenergic receptor 3D structures]] |
+ | *[[Beta-2 adrenergic receptor|Beta-2 adrenergic receptor]] | ||
*[[Lysozyme 3D structures|Lysozyme 3D structures]] | *[[Lysozyme 3D structures|Lysozyme 3D structures]] | ||
== References == | == References == | ||
Line 27: | Line 28: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
+ | [[Category: Escherichia virus T4]] | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
- | [[Category: | + | [[Category: Large Structures]] |
- | [[Category: Aragao | + | [[Category: Aragao D]] |
- | [[Category: Arlow | + | [[Category: Arlow DH]] |
- | [[Category: Caffrey | + | [[Category: Caffrey M]] |
- | [[Category: Chae | + | [[Category: Chae PS]] |
- | [[Category: Choi | + | [[Category: Choi H-J]] |
- | [[Category: DeVree | + | [[Category: DeVree BT]] |
- | [[Category: Dror | + | [[Category: Dror RO]] |
- | [[Category: Gellman | + | [[Category: Gellman SH]] |
- | [[Category: Gmeiner | + | [[Category: Gmeiner P]] |
- | [[Category: Holl | + | [[Category: Holl R]] |
- | [[Category: Kobilka | + | [[Category: Kobilka BK]] |
- | [[Category: Lyons | + | [[Category: Lyons JA]] |
- | [[Category: Rasmussen | + | [[Category: Rasmussen SGF]] |
- | [[Category: Rosenbaum | + | [[Category: Rosenbaum DM]] |
- | [[Category: Shaw | + | [[Category: Shaw DE]] |
- | [[Category: Sunahara | + | [[Category: Sunahara RK]] |
- | [[Category: Weis | + | [[Category: Weis WI]] |
- | [[Category: Zhang | + | [[Category: Zhang C]] |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + |
Current revision
Irreversible Agonist-Beta2 Adrenoceptor Complex
|
Categories: Escherichia virus T4 | Homo sapiens | Large Structures | Aragao D | Arlow DH | Caffrey M | Chae PS | Choi H-J | DeVree BT | Dror RO | Gellman SH | Gmeiner P | Holl R | Kobilka BK | Lyons JA | Rasmussen SGF | Rosenbaum DM | Shaw DE | Sunahara RK | Weis WI | Zhang C